Tomorrow's Cure

When a child is critically ill and answers are elusive, every day can feel like an eternity. This week on Tomorrow’s Cure from Mayo Clinic, host Cathy Wurzer talks with pediatric geneticist Whitney Thompson, M.D., from Mayo Clinic, genomic medicine pioneer Stephen Kingsmore, M.D., DSc, from Rady Children’s Institute for Genomic Medicine, and Sean George, Ph.D., CEO of Inflection Medicine, about how rapid whole genome sequencing is transforming care for the youngest patients.

Together, they explore how clinicians are shortening the “diagnostic odyssey,” pairing sequencing with artificial intelligence to identify potential treatments, and redefining what is possible for rare diseases through programs like Mayo Clinic Children’s BabyFORce. You will also hear powerful patient stories, including children whose lives changed after a genomic diagnosis opened the door to targeted therapies, and a candid discussion about cost, access, and ethics as this technology moves toward wider adoption. Tune in to learn how today’s breakthroughs in pediatric genomics could shape the future of medicine for all of us.

How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: ⁠https://mayocl.in/3EcNPNc⁠

Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/⁠Follow • Mayo Clinic on Instagram: ⁠https://www.instagram.com/mayoclinic/⁠Follow • Mayo Clinic on X (formerly Twitter): ⁠https://x.com/MayoClinic⁠Follow • Mayo Clinic on Threads: ⁠https://www.threads.net/@mayoclinic

Automation is quietly reshaping what happens before, during, and after a medical visit, and for many patients it is almost invisible. In this episode of Tomorrow’s Cure, host Cathy Wurzer talks with Mayo Clinic physician leader Dr. Anjali Bhagra and human centered AI expert Dr. Ravi Bapna about how automation and artificial intelligence are changing the way care teams work, how patients access care, and what it takes to keep people at the center of these advances.

They share real stories from clinic and hospital settings, including tools that automatically generate notes from complex visits, systems that help triage patients more quickly around the world, and AI that supports earlier diagnosis. The conversation also tackles the hard questions around trust, bias, and burnout. Listeners will hear how thoughtful automation can free up time for human connection and why the future of healthcare is people and technology working together in new ways.

How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: ⁠https://mayocl.in/3EcNPNc⁠

Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/⁠Follow • Mayo Clinic on Instagram: ⁠https://www.instagram.com/mayoclinic/⁠Follow • Mayo Clinic on X (formerly Twitter): ⁠https://x.com/MayoClinic⁠Follow • Mayo Clinic on Threads: ⁠https://www.threads.net/@mayoclinic

For a century, Mayo Clinic Proceedings has captured the evolution of modern medicine, from pioneering cortisone therapy to today’s breakthroughs in artificial intelligence and digital diagnostics. In this episode of Tomorrow’s Cure from Mayo Clinic, host Cathy Wurzer talks with Editor in Chief Dr. Karl Nath and hematologist and longtime contributor Dr. Vincent Rajkumar about the journal’s origins, its global influence, and how it helps physicians turn complex science into practical care.​

They explore innovations such as AI enabled ECGs that can reveal hidden heart rhythm problems, voice biomarkers that may flag cardiovascular disease from a simple speech sample, stem cell approaches for spinal cord injury, and novel therapies that emerged from Mayo Clinic Proceedings and went on to reshape clinical practice.Listen to hear how Mayo Clinic Proceedings is preparing for its second century as a trusted guide to evidence based medicine.

How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: ⁠https://mayocl.in/3EcNPNc⁠

Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/⁠Follow • Mayo Clinic on Instagram: ⁠https://www.instagram.com/mayoclinic/⁠Follow • Mayo Clinic on X (formerly Twitter): ⁠https://x.com/MayoClinic⁠Follow • Mayo Clinic on Threads: ⁠https://www.threads.net/@mayoclinic

Cardiovascular disease remains the leading cause of death in the United States, yet new science and smarter systems are changing what is possible for patients and families. In this episode of Tomorrow’s Cure, host Cathy Wurzer talks with three leaders who are reshaping how we prevent, understand, and treat heart disease and obesity.

Mayo Clinic gastroenterologist Dr. Andres Acosta explains why obesity is not “one size fits all” and how phenotype based, precision treatments can double weight loss success and reduce cardiovascular risk. American Heart Association CEO Nancy Brown explores why heart disease still claims so many lives, how social and economic forces drive risk, and what it will take to improve health for every community. Dr. Kevin Volpp, scientific lead of the AHA Food is Medicine initiative, shares how medically tailored meals and behavioral economics could cut costly hospital readmissions and make healthy eating more affordable. Listen to hear personal stories, practical takeaways, and a hopeful look at the future of heart health.

How to listen and stay connected:


Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.


Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc

Connect with Mayo Clinic:


Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/


Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/


Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic


Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic

Rheumatoid arthritis is often seen as “just” joint pain, but Mayo Clinic rheumatologist Dr. John Davis and University of Colorado researcher Dr. Kevin Deane reveal a far more complex and promising story. In this episode of Tomorrow’s Cure, host and journalist Cathy Wurzer explores how autoimmune disease can quietly develop for years before the first swollen joint, and how new blood tests, gut microbiome insights, and the exposome, our lifetime of environmental exposures such as cigarette smoke and wildfire haze, are helping clinicians see risk much earlier.

The conversation dives into emerging tools that use artificial intelligence to sift through genetics, autoantibodies, microbiome data, and real-world exposures to predict who is most likely to develop rheumatoid arthritis and who will respond to specific treatments. Hear how prevention trials, lessons from type 1 diabetes, and more virtual models of care could change what it means to live with, or even avoid, rheumatoid arthritis in the future.

How to listen and stay connected:


Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.


Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc

Connect with Mayo Clinic:


Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/


Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/


Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic


Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic